Regulation of murine interleukin-10 production by dehydroepiandrosterone

Journal of Interferon and Cytokine Research

Volumn 20, Issue 5, 2000, Pages 471-478

  Cheng, Guey Fang ^a   Tseng, Jerming ^a  

^a NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; MESSENGER RNA; PRASTERONE; PRASTERONE SULFATE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HORMONAL REGULATION; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DNA PRIMERS; IMMUNOGLOBULINS; INTERLEUKIN-10; MALE; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; RNA, MESSENGER; SPLEEN;

ANIMALIA; MURINAE;

EID: 0034125051     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900050023889     Document Type: Article

References (27)

1. 1. VERMEULEN, A. (1995). Dehydroepiand rosterone sulfate and aging. Ann. NY Acad. Sci. 774, 121-127.
2. 2. ROBEL, P., and BAULIUE, E.-E. (1995). Dehydroepiandr osterone (DHEA) is a neuroactive neurosteroid. Ann. NY Acad. Sci. 774, 82-110.
3. 3. LORIA, R.M., INGE, T.H., COOK, S.S., SZAKAL, A.K., and REGELSON, W. (1988). Protection against acute lethal viral infections with the native steroid (DHEA). J. Med. Virol. 26, 301-314.
4. 4. ROM, W.N., and HARKIN, T. (1990). Dehydroepiandr osterone inhibits the spontaneous release of superoxide radical by alveolar macrophage in vitro in asbestosis. Environ. Res. 55, 145-156.
5. 5. RISDON, G., KUMAR, V., and BENNETT, B. (1991). Differential effects of dehydroepiandr osterone (DHEA) on murine lymphopoiesis and myelopoiesis. Exp. Hematol. 19, 128-131.
6. 6. HIDVEGI, T., FEHER, G.K., HEHER, T., KOO, E., and FUST, G. (1984). Inhibition of complement activation by an adrenal androgen, dehydroepiandrosterone. Complement 1, 201-206.
7. 7. DAYNES, R.A., DUDIAY, D.J., and ARANEO, A.B. (1990). Regulation of murine lymphokine production in vivo: II. Dehydroepiandrosterone is a natural enhancer of interleukin-2 synthesis by helper T cells. Eur. J. Immunol. 20, 793-802.
8. 8. SUZUKI, T., SUZUKI, N., DAYNES, R.A., and ENGLEMAN, E.G. (1991). Dehydroepiandrosterone enhances IL-2 production and cytotoxic effector function of human T cell. Clin. Immunol. 61, 202-211.
9. 9. MOYNIHAN, J.A., CALLAHAN, T.A., KELLEY, S.P., and CAMPBELL, L.M. (1998). Adrenal hormone modulation of type 1 and type 2 cytokine production by spleen cells: dexamethasone and dehydroepiandro sterone suppress interleukin-2, interleukin-4, and interferon-γ production in vitro. Cell. Immunol. 184, 58-64.
10. 10. WU, M.-F., CHANG, H.-L., and TSENG, J. (1997). Dehydroepiandrosterone induces transforming growth factor-β production by murine macrophages. Int. J. Tissue React. 19, 141-148.
11. 11. SANTO, E.D., SIRONI, M., MENNINI, T., ZINETTI, M., SAVOLDI, G., LORENZO, D.D., and GHEZZI, P. (1996). A glucocorticoid receptor-independent mechanism for neurosteroid inhibition of tumor necrosis factor production. Eur. J. Pharmacol. 299, 179-186.
12. 12. DANENBERG, H.D., ALPERT, G., LUSTIG, S., and BENNATHAN, D. (1992). Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Microbiol. Agent Chemother. 36, 2275-2279.
13. 13. McLACHLAN, J.A., SERKIN.C.D., and BAKOUCHE, O. (1996). Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J. Immunol. 156, 328-335.
14. 14. DELPEDRO, A.D., BARJAVEL, M.J., MAMDOUH, Z., and BAKOUCH, O. (1998). Activation of human monocytes by LPS and DHEA. J. Interferon Cytokine Res. 18, 125-135.
15. 15. TSENG, J., and LIU, C.-J. (1994). Dehydroepiandrosterone regulates immunoglobulin A production of murine B lymphocytes. Int. J. Immunother. 10, 95-101.
16. 16. LUCAS, J.A., AHMED, S.A., CASCY, M.L., and MACDONALD, P.C. (1985). Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroepiandrosterone. J. Clin. Invest. 75, 2091-2093.
17. 17. VAN VOLLENHOVEN, R.F., ENGLEMAN, E.G., and McGUIRE, J.L. (1995). Dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum. 38, 1826-1831.
18. 18. MOORE, K.W., O'GARRA, A., MALEFYT, R.DE W., VIEIRA, P., and MOSMANN, T.R. (1993). Interleukin-10. Annu. Rev. Immunol. 11, 165-190.
19. 19. MOORE, K.W., VIEIRA, P., FIORENTINO, D.F., TROUNSTINE, M.L., KHAN, T.A., and MOSMANN, T.R. (1990). Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248, 1230-1234.
20. 20. DEL PRETE, G. DE CARLI, M., ALMERIGOGNA, F., GIUDIZI, M.G., BIAGIOTTI, R., and ROMAGNANI, S. (1993). Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150, 353-360.
21. 21. WANIDWORANUN, C., and STROBER, W. (1993). Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J. Immunol. 151, 6853-6861.
22. 22. DE WAAL MALEFYT, R., ABRAMS, J., BENNETT, B., FIGDOR, C.G., and DE VRIES, J.E. (1991). Interkeukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
23. 23. THOMPSON-SNIPES, L., DHAR, V., BOND, M.W., MOSMANN, T.R., MOORE, K.W., and RENNICK, D. (1991). Interleukin-10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173, 507-510.
24. 24. KUHN, R., LOHLER, J., RENNICK, D., RAJEWSKY, K., and MULLER, W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-270.
25. 25. ROUSSET, F., GARCIA, E., DEFRANCE, T., PERONNE, C., VEZZIO, N., HSU, D.-H., KASTELEIN, R., MOORE, K.W., and BANCHEREAU, J. (1992). Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89, 1890-1893.
26. 26. FALANY, C.N., COMER, K.A., DOOLEY, T.P., and GLATT, H. (1995). Human dehydroepiandro sterone sulfotransferase: purification, molecular cloning, and characterization. Ann. NY Acad. Sci. 774, 59-72.
27. 27. ARANEO, B.A., WOODS, M.L., II, and DAYNES, R.A. (1993). Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J. Infect. Dis. 167, 830-840.